About GERBU Biotechnik
The mission of GERBU Biotechnik GmbH is to ensure reliable supply of Biochemicals at the most affordable prices and exceptional quality. Our prime focus is to diversify global trade through impeccable networking , responsible approach, observance of sustainability and thus creating a notable presence worldwide.
GERBU Biotechnik GmbH was founded in 1986 by Nikolaus Grubhofer, starting with a small range of common Biochemicals and systematically expanding its capacity for production and trade.
For more than 30 years GERBU has developed itself in establishing raw material sourcing, manufacturing and active trading with our long-term partners and trusted customers. We are committed in providing our valuable customers and partners outstanding service with principle approach of careful selection, prioritization and credibility assurance.
Our key product range includes Biochemicals, Reagents, Immunoadjuvants for antibody production, Immunomodulators, Buffers and other unique and sophisticated products designed by our partners to make your research a success.
GERBU Biotechnik GmbH is ISO 9001: 2015 Certified
- Focus : Distributor
- Industry : Biotechnology
Product portfolio of GERBU Biotechnik
Here you will find GERBU Biotechnik GmbH
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
